Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Levofloxacin exerts broad-spectrum anticancer activity via regulation of THBS1, LAPTM5, SRD5A3, MFAP5 and P4HA1

Published:2021-08-19 Issue:1 Volume:33 Page:e235-e246
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

He Xiaoqiong,Yao Qian,Hall Duane D,Song Zhongyu,Fan Dan,You Yutong,Lian Wenjing,Zhou Zhangping,Duan Ling,Chen Biyi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference38 articles.

1. Global cancer statistics, 2012.;Torre;CA Cancer J Clin,2015

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018

3. Overview on anticancer drug design and development.;Olgen;Curr Med Chem,2018

4. Understanding cancer drug resistance by developing and studying resistant cell line models.;Xavier;Curr Cancer Drug Targets,2016

5. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.;Karasawa;Toxicol Lett,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The function and mechanism of LAPTM5 in diseases;Biomedicine & Pharmacotherapy;2024-09

2. Drug repurposing study of levofloxacin: Structural properties, lipophilicity along with experimental and computational DNA binding;Journal of Molecular Liquids;2024-08

3. Recent Development of Fluoroquinolone Derivatives as Anticancer Agents;Molecules;2024-07-27

4. P4HA1 expression and function in esophageal squamous cell carcinoma;Medicine;2023-12-22

5. Combination of Cefotaxime and Cisplatin Specifically and Selectively Enhances Anticancer Efficacy in Nasopharyngeal Carcinoma;Current Cancer Drug Targets;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3